Authors:
Anker, SD
Volterrani, M
Pflaum, CD
Strasburger, CJ
Osterziel, KJ
Doehner, W
Ranke, MB
Poole-Wilson, PA
Giustina, A
Dietz, R
Coats, AJS
Citation: Sd. Anker et al., Acquired growth hormone resistance in patients with chronic heart failure:Implications for therapy with growth hormone, J AM COL C, 38(2), 2001, pp. 443-452
Authors:
Cleland, JGF
Thygesen, K
Uretsky, BF
Armstrong, P
Horowitz, JD
Massie, B
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Jgf. Cleland et al., Cardiovascular critical event pathways for the progression of heart failure - A report from the ATLAS study, EUR HEART J, 22(17), 2001, pp. 1601-1612
Authors:
Bjornstad, H
Solal, AC
Dubach, P
Fioretti, PM
Giannuzzi, P
Hambrecht, R
Hellemans, I
McGee, H
Mendes, M
Perk, J
Saner, H
Verres, G
Brutsaert, DL
Cleland, JGF
Dresler, H
Erhardt, L
Ferrari, R
van Gilst, WH
Komajda, M
Madeira, H
Mercadier, JJ
Nieminen, M
Poole-Wilson, PA
Rieger, GAJ
Ruzillo, W
Swedberg, K
Tavazzi, L
Citation: H. Bjornstad et al., Recommendations for exercise testing in chronic heart failure patients, EUR HEART J, 22(1), 2001, pp. 37-45
Citation: Dj. Van Veldhuisen et Pa. Poole-wilson, The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure, INT J CARD, 80(1), 2001, pp. 19-27
Authors:
Ponikowski, P
Chua, TP
Anker, SD
Francis, DP
Doehner, W
Banasiak, W
Poole-Wilson, PA
Piepoli, MF
Coats, AJS
Citation: P. Ponikowski et al., Peripheral chemoreceptor hypersensitivity - An ominous sign in patients with chronic heart failure, CIRCULATION, 104(5), 2001, pp. 544-549
Authors:
Ponikowski, P
Francis, DP
Piepoli, MF
Davies, LC
Chua, TP
Davos, CH
Florea, V
Banasiak, W
Poole-Wilson, PA
Coats, AJS
Anker, SD
Citation: P. Ponikowski et al., Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance - Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis, CIRCULATION, 103(7), 2001, pp. 967-972
Authors:
Massie, BM
Armstrong, PW
Cleland, JGF
Horowitz, JD
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Bm. Massie et al., Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial, ARCH IN MED, 161(2), 2001, pp. 165-171
Authors:
Fox, KF
Cowie, MR
Wood, DA
Coats, AJS
Poole-Wilson, PA
Sutton, GC
Citation: Kf. Fox et al., A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community, EUR J HE FA, 2(4), 2000, pp. 423-429
Authors:
Sculpher, MJ
Poole, L
Cleland, J
Drummond, M
Armstrong, PW
Horowitz, JD
Massie, BM
Poole-Wilson, PA
Ryden, L
Citation: Mj. Sculpher et al., Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study, EUR J HE FA, 2(4), 2000, pp. 447-454
Authors:
Greenhalgh, RM
Powell, JT
Fowkes, FGR
Forbes, JF
Ruckley, CV
Poole-Wilson, PA
Browse, N
Bulpitt, CJ
Burnand, K
Coles, EC
Fletcher, A
Blair, S
Clark, R
Devine, C
Ferguson, K
Hearn, S
Kerracher, E
Logan, S
McCabe, A
Meer-Baloch, R
Mossa, M
Rattray, A
Wilson, K
Brown, L
Franks, P
Keen, N
Rose, C
Hassaine, RM
Horrocks, M
Budd, J
Horrocks, M
Baird, RN
Lamont, P
Wilkins, DC
Ashley, S
Flowerdew, K
Baker, A
Earnshaw, J
Heather, B
Gibbons, C
Blackett, RL
Parvin, SD
Harvey, DR
Hedges, R
Finch, D
Hocken, DB
Morris, GE
Shearman, CP
Lear, P
Lewis, P
Clarke, RJ
Ruckley, CV
Jenkins, AM
Ruckley, CV
Cooper, GG
Engeset, J
Naylor, R
Stewart, G
Cumming, J
McCormick, J
Howd, A
Turner, A
Harper, DR
Smith, RC
Chamberlain, J
Jones, AG
Wyatt, MG
McKay, AJ
Forrester, JC
McCollum, P
Stonebridge, PA
Davidson, AIG
Baker, R
Forsythe, JLR
Lambert, D
Duncan, JL
Bell, PRF
Ratliff, D
Callum, KG
Nash, JR
McPherson, DS
Jenner, RE
Stewart, R
Armitstead, PR
Barrie, WW
Hamer, DB
Powis, S
Coen, LD
Michaels, J
Welsh, CL
Hopkinson, BR
Wenham, PW
Beard, J
Auckland, A
Black, J
Downing, R
Hickey, NC
Greenhalgh, RM
Davies, AH
Greenhalgh, RM
Nott, D
May, ARL
McFarland, R
Taylor, P
Bradley, JWP
Paes, T
Cameron, AEP
McIrvine, A
Negus, D
Taylor, PR
Butler, CM
Hoile, RW
Pardy, B
Ackroyd, J
Hamilton, G
Lane, R
Giddings, AEB
Dormandy, J
Taylor, R
Thomas, M
Burnand, KJ
Adiseshiah, M
Pattison, P
Clarke, J
Colin, J
Rutter, P
Brearley, S
Pietroni, M
McCollum, CN
Greaney, MG
Reilly, D
Paley, WG
Lambert, M
Hughes, R
Blair, S
Shand, JEG
Donaldson, LA
Galloway, JMD
Wilkinson, AR
Gough, M
Mosley, J
Matheson, DM
Walker, M
Hulton, N
Aldoori, MI
Yeung, CK
Hearn, AR
Kelly, J
Durrans, D
Gwynn, B
Hopkinson, GB
Duffield, RGM
Schraibman, IG
Hall, R
Leveson, SH
Clark, J
Klimach, O
Citation: Rm. Greenhalgh et al., Smoking, lung function and the prognosis of abdominal aortic aneurysm, EUR J VAS E, 19(6), 2000, pp. 636-642
Authors:
Sharma, R
Rauchhaus, M
Ponikowski, PP
Varney, S
Poole-Wilson, PA
Mann, DL
Coats, AJS
Anker, SD
Citation: R. Sharma et al., The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors, J AM COL C, 36(2), 2000, pp. 523-528
Authors:
Ryden, L
Armstrong, PW
Cleland, JFG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Citation: L. Ryden et al., Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus - Results from the ATLAS trial, EUR HEART J, 21(23), 2000, pp. 1967-1978
Authors:
Leyva, F
Rauchhaus, M
Anker, SD
Proudler, AJ
Godsland, IF
Stiefel, P
Coats, AJS
Poole-Wilson, PA
Stevenson, JC
Citation: F. Leyva et al., Non-invasive assessment of vascular function - Paradoxical vascular response to intravenous glucose in coronary heart disease, EUR HEART J, 21(1), 2000, pp. 39-44
Authors:
Pitt, B
Poole-Wilson, PA
Segal, R
Martinez, FA
Dickstein, K
Camm, AJ
Konstam, MA
Riegger, G
Klinger, GH
Neaton, J
Sharma, D
Thiyagarajan, B
Citation: B. Pitt et al., Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II, LANCET, 355(9215), 2000, pp. 1582-1587
Authors:
Uretsky, BF
Thygesen, K
Armstrong, PW
Cleland, JG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Bf. Uretsky et al., Acute coronary findings at autopsy in heart failure patients with sudden death - Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial, CIRCULATION, 102(6), 2000, pp. 611-616
Citation: Pdv. Bourdillon et Pa. Poole-wilson, Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium, CARDIO RES, 45(1), 2000, pp. 95-96
Citation: Pdv. Bourdillon et Pa. Poole-wilson, Commentary on "Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium", CARDIO RES, 45(1), 2000, pp. 97-99